What are “unoready” and “sensoready” for Cosentyx?
Cosentyx comes in different pen and injector devices that deliver the same medicine (secukinumab). “Sensoready” and “Unoready” refer to the device versions, not to different drugs. The main differences are usually the way the device works (for example, feedback and guidance during injection) and how it’s designed to be used.
Are unoready and sensoready different treatments or doses?
They are intended to deliver the same active ingredient—secukinumab—at the same labeled strength and dosing schedules for Cosentyx (based on the condition being treated). The device label changes, not the underlying medication.
How do patients typically experience the devices?
Device versions often differ in user interaction. Some versions provide more visible or audible confirmation that an injection is complete and can make it easier to know when to stop or when the dose has delivered. In practice, that can matter for people who prefer clearer feedback during self-injection.
Which one is better—unoready or sensoready?
“Better” depends on what you want from the injection experience:
- If you want the most guided or confirmation-style feedback, a “sensoready” style device may fit better.
- If you prefer a simpler pen/injector experience, a “unoready” style device may feel easier.
Your choice should also match what your pharmacy/insurance provides and what your clinician recommends for your specific dosing regimen.
What should you check before switching devices?
Before switching between device versions, check:
- That both are Cosentyx (secukinumab) with the same dose and dosing schedule.
- The correct device training for the new pen/injector type.
- Any instructions in your prescription packaging for how to store and inject that exact device.
If you tell me which exact Cosentyx product you’re considering (the strength and formulation, and whether it’s a pen or prefilled syringe), I can help compare the practical differences more precisely.